Divyansh Mangal is Co-Founder and Director at Aignosis, a Jaipur-based healthtech startup building India's premier AI-powered developmental disorder and autism screening platform using computer vision and behavioral biomarkers.

A physicist-turned-AI engineer, Divyansh holds an Integrated Masters of Physics from BITS Pilani and a Masters from the University of Gdansk, and previously conducted quantum research at the International Centre for Theory of Quantum Technologies (ICTQT), developing a self-testing Quantum Random Number Generator for satellite applications.

Inspired by growing up in a family of pediatricians and witnessing the devastating impact of late autism diagnoses, Divyansh co-founded Aignosis to make early detection accessible, affordable, and scalable for underserved communities across India.

Aignosis has been backed by Shark Tank India investors Amit Jain and Nikhil Kamath, WTFund, and Antler, raising a seed round of Rs 4 crore, and has achieved CDSCO Class B medical certification and selection into the Google for Startups Accelerator: AI First 2025 cohort.

Aignosis has completed over 8,000 autism screenings, deployed across more than 20 government primary health centres in Rajasthan, and partnered with Mankind Pharma, targeting 100,000 screenings by the end of FY27.